Results 61 to 70 of about 96,811 (318)

Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds

Advanced NanoBiomed Research, EarlyView.
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh, Mahsa Mohammadzadeh, Amir Abbas Seraji, Ali Pirsadeghi, Elham Zendedel, Maliheh Gharibshahian   +5 more
wiley   +1 more source

Everolimus-eluting stents in interventional cardiology

Vascular Health and Risk Management, 2012
Jacob C Townsend, Phillip Rideout, Daniel H SteinbergDivision of Cardiology, Medical University of South Carolina, Charleston, SC, USAAbstract: Bare metal stents have a proven safety record, but limited long-term efficacy due to in-stent restenosis ...
Townsend JC, Rideout P, Steinberg DH
doaj  

Redox‐Responsive Mitochondrial Delivery from Functionalized Vascular Stent Surfaces

Advanced NanoBiomed Research, EarlyView.
A redox‐responsive stent surface is engineered to deliver functional mitochondria in response to oxidative stress. Upon exposure to reactive oxygen species, grafted mitochondria are released, internalized by vascular cells, and restore mitochondrial function under stress.
Fang Tang, Brandon C. Applewhite, Bowen Wang, Bin Jiang   +3 more
wiley   +1 more source

Drug-eluting stents : Insights into safety and indications

Annals of Saudi Medicine, 2008
Currently, more than 4 million patients receive drug-eluting stents worldwide. Despite recent studies and editorials that have stirred controversy and generated tremendous publicity in the lay press related to the safety of drug-eluting stents for the ...
Hassan Walid
doaj  

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease

SAGE Open Medicine, 2017
Objectives: To compare the efficacy and safety of percutaneous coronary intervention using second-generation drug-eluting stents with those of coronary artery bypass grafting among patients with multivessel disease and/or unprotected left main coronary ...
Kyriacos Papadopoulos, Ioannis Lekakis, Evagoras Nicolaides   +2 more
doaj   +1 more source

Application of underdamped Langevin dynamics simulations for the study of diffusion from a drug-eluting stent

, 2018
We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core   +1 more source

Drug Eluting Stents en Belgique

, 2007
A côté des« stents » métalliques classiques, il y a, depuis quelques années, aussi des stents spéciaux avec médicament incorporé, pour traiter le rétrécissement des artères coronaires : les « drug eluting stents ». Le médicament est supposé empêcher une nouvelle constriction de l’artère. Quelle est l’efficacité de cette nouvelle technique ? A-t-elle un
Neyt, Mattias, Van Brabandt, Hans, Devriese, Stephan, Mahieu, Joris, De Ridder, Annemieke, De Graeve, Diana, De Laet, Chris   +6 more
openaire   +1 more source

Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents—Brief Report

Arteriosclerosis, Thrombosis and Vascular Biology, 2018
Objective— Drug-eluting stents eluting canonical mTOR (mammalian target of rapamycin) inhibitors are widely used to treat coronary artery disease but accelerate the development of atherosclerosis within the stent (neoatherosclerosis)—a leading cause of ...
Emanuel Harari, Liang Guo, Samantha L. Smith, K. Paek, Raquel Fernandez, A. Sakamoto, Hiroyoshi Mori, Matthew D. Kutyna, Anwer Habib, S. Torii, A. Cornelissen, H. Jinnouchi, Anuj Gupta, F. Kolodgie, R. Virmani, A. Finn   +15 more
semanticscholar   +1 more source

Radial capacity and hemodynamics evaluation in vitro and implantable feasibility validation in vivo of thinner bioresorbable polymer vascular stents

BMEMat, EarlyView.
A series of in vitro experiments, numerical simulations and in vivo experiments were conducted to jointly evaluate the effects of different thicknesses of bioabsorbable polymer vascular stents on their radial capacity, hemodynamics and in vivo outcomes.
Chong Chen, Tao Li, Zhongyou Li, Jingyuan Zhou, Zhuo Zhang, Yan Xiong, Rifang Luo, Yu Chen, Yunbing Wang, Ping Fu   +9 more
wiley   +1 more source

Advances in Drug Delivery via Biodegradable Ureteral Stent for the Treatment of Upper Tract Urothelial Carcinoma

Frontiers in Pharmacology, 2020
Drug eluting ureteral stent is an effective means for local drug delivery to the urinary tract. It can potentially solve a variety of upper urinary tract problems, such as stent-related urinary tract infections and discomfort, ureteral stricture, and ...
Hongli Shan, Zhongshuai Cao, Changliang Chi, Jixue Wang, Xiaoqing Wang, Jingyan Tian, Bing Yu   +6 more
doaj   +1 more source